Açıklama
Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders.
Figure 27
DiagramSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 27: Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders." /> <figcaption>Figure 27. Multi-organ crosstalk diagram showing the systemic effects of gut microbiota modulation on liver, adipose tissue, pancreas, and cardiovascular function in the context of metabolic disorders.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>